Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 97,281 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lyra Therapeutics Inc | LYRA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0002 | -0.06% | 0.3278 | 07:28:05 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.328 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 156 | 97,281 | - | 0.31 - 6.79 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:28:38 | 50 | US$ 0.3272 | USD |
Lyra Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 17.35M | 52.56M | - | 1.56M | -62.68M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lyra Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LYRA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3267 | 0.3393 | 0.3201 | 0.3313159 | 1,241,830 | 0.0011 | 0.34% |
| 1 Month | 0.3914 | 0.75 | 0.31 | 0.4631904 | 9,620,356 | -0.0636 | -16.25% |
| 3 Months | 5.31 | 6.79 | 0.31 | 0.9068719 | 3,454,671 | -4.98 | -93.83% |
| 6 Months | 3.62 | 6.79 | 0.31 | 1.22 | 1,750,111 | -3.29 | -90.94% |
| 1 Year | 3.19 | 6.79 | 0.31 | 1.60 | 1,016,522 | -2.86 | -89.72% |
| 3 Years | 7.76 | 9.98 | 0.31 | 2.15 | 389,229 | -7.43 | -95.78% |
| 5 Years | 21.00 | 22.00 | 0.31 | 3.14 | 315,222 | -20.67 | -98.44% |
Lyra Therapeutics Description
| Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. |
